Laser delivery platforms

Article

Breaking news from the floor of ESCRS

Lumenis has been displaying its range of photocoagulation and laser delivery technologies at ESCRS. Among the products on display is the company’s fully integrated, advanced laser delivery technology and slit lamp biomicroscope; Insight. According to the company this biomicroscope represents the latest in retina visualization. It is reported to address some of the well known challenges in ophthalmic laser delivery devices, including clear visualization of the retina, (including the periphery) and precise laser delivery to the target tissue. The device also features the company’s unique co-linear (CoLin) design that projects both illumination and laser beam on the same pathway.

The company also featured the Selecta Duet, which combines the company’s SLT technology with a YAG photodisruptor in a single platform.

The company’s Selecta Trio offers retinal, cataract and glaucoma therapies in a single platform. According to the company the integrated design, enhanced optics system and advanced laser cavity provide maximum flexibility and minimum footprint. It provides all the advantages of the Duet in SLT and VAG modes, but with the propriety advantages in photocoagulation mode.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.